Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Current P/E vs estimated settlement dollars

In addition to the possibility that the P/E could be more emotional than my example, the outstanding share count could (probably) is less than what I used. If I reduce my share count by 10 Million, that would calculate to and additional .12 cent per share on the low end and .42 cent a share on the high end of my example.

Here's to an agressive buy back strategy why the price is low.


Dec 11, 2007 10:52AM
Share
New Message
Please login to post a reply